In a groundbreaking advancement from China, a plant-based compound derived from Chinese celery, called nitroabutyl phthalide (NBP), is now approved for treating stroke patients. Through phase three clinical trials, NBP has demonstrated the ability to limit brain damage, encourage stem cell activity, and promote brain regeneration after a stroke. Discover how this natural compound could change the future of stroke treatment and brain recovery, offering hope for millions worldwide. 

View this post on Instagram